Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 10, Issue 12, Pages 1496-1500Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2010.06.019
Keywords
Mesenchymal stem cells; Immunomodulation; Cytokines; Prostaglandins; Immune therapy; Organ transplantation
Categories
Ask authors/readers for more resources
There is growing interest in the use of mesenchymal stem cells (MSC) for immune therapy. Clinical trials that use MSC for treatment of therapy resistant graft versus host disease, Crohn's disease and organ transplantation have initiated. Nevertheless, the immunomodulatory effects of MSC are only partly understood. Clinical trials that are supported by basic research will lead to better understanding of the potential of MSC for immunomodulatory applications and to optimization of such therapies. In this manuscript we review some recent literature on the mechanisms of immunomodulation by MSC in vitro and animal models, present new data on the secretion of pro-inflammatory and anti-inflammatory cytokines, chemokines and prostaglandins by MSC under resting and inflammatory conditions and discuss the hopes and expectations of MSC-based immune therapy. (C) 2010 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available